The MarketWatch News Department was not involved in the creation of this content. -- Co-chaired by Her Royal Highness Dr. Haya bint Khaled Al Saud, His Excellency Dr. Bandar Alknawy, and Dr. Patrick ...
ImmunityBio Reports Productive Regulatory Engagement with Saudi Food and Drug Authority at USA-Saudi Biotech Alliance Meeting Hosted by the Ministry of Investment of Saudi Arabia Saudi FDA (SFDA) ...
Dear reader, the history of the pharmaceutical industry in the Kingdom is a remarkable story of transformation. It began with ...
NYSE Content Advisory: Pre-Market Update + Inaugural U.S.-Saudi Biotech Alliance Summit Begins in SF
U.S. equities traded fractionally lower pre-market as investors digest a packed agenda, including earnings from major banks, speeches from several Fed officials, key economic data, and a possible ...
Dr. Alfayyadh emphasized that Saudi Arabia’s biotech transformation is driven by an ambitious national vision to become a global medical-innovation hub by 2040, supported by integrated research, ...
SFDA is supporting safer food systems, more effective health care regulation and a stronger environment for research ...
NantWorks, LLC, and ImmunityBio, Inc. ( NASDAQ: IBRX), today announced the inaugural U.S.-Saudi Biotech Alliance Summit, to be held in conjunction with the 44th Annual J.P. Morgan Healthcare ...
Saudi FDA (SFDA) Encouraged Company to Submit Regulatory File for Recombinant BCG and Discussions Initiated for the Expansion of ANKTIVA ® in Combination with Checkpoint Inhibitors Across Multiple ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results